Scott Biller, Chief Scientific Officer at AGIOS PHARMACEUTICALS INC (AGIO), sold 2,992 shares at $60.63 ($182K) on 2017-12-01, disclosed to the SEC on 2017-12-05.
Seasonal sale ($182k) by Chief Scientific Officer — this insider has traded AGIO in December in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $59.89 | 600 | $36K | 19.8% |
| 2 | $60.63 | 846 | $51K | 28.2% |
| 3 | $60.63 | 846 | $51K | 28.2% |
| 4 | $61.76 | 700 | $43K | 23.8% |
| Total | $60.75 avg | 2,992 | $182K | 100% |
| Filing → |
| AGIO | SELL | 2019-03-01 | $585K | — | Filing → |
| AGIO | SELL | 2018-11-07 | $209K | — | Filing → |
| AGIO | SELL | 2018-10-09 | $277K | — | Filing → |